Home
Our ServicesConnect Education WorkshopsTagged: Treatment
HomeOur ServicesConnect Education WorkshopsTagged: Treatment
Connect Education Workshops About Treatment
You can also browse all resources about treatment»
Upcoming Workshops
For Breast Cancer
For Leukemia
For Mantle Cell Lymphoma
For Multiple Myeloma
- Part I of Living with Multiple MyelomaRegister
Past workshops
For All Cancers
- Understanding the Different Names for Biomarker Testing and Their Role in Selecting the Best Treatment for YouPart II of What You Need to Know About Biomarkers in the Treatment of Cancer Makes All the Difference in the World
- Clinical Trials: How They Transform the Treatment of Cancer
- Chemotherapy: Novel Approaches to Prevent and Manage Gastrointestinal Treatment Side Effects
- Current Perspectives on the Future of Cancer Research
- How Health Care Disparities May Influence Your Cancer Treatment
- Diverse Populations Participating in Decisions about Your Care
- Managing Eye and Vision Changes Related to Cancer Treatments
- Understanding the Different Names for Biomarker Testing & Their Role in Selecting the Best Treatment for YouPart II of The Important Role of Biomarker Testing in the Treatment of Cancer: What You Need to Know Makes All the Difference in the World
- Chemotherapy: Novel Approaches to Prevent and Manage Gastrointestinal Treatment Side Effects
- Understanding the Important Role that Biomarker Testing Plays in Informing the Treatment of CancerPart I of The Important Role of Biomarker Testing in the Treatment of Cancer: What You Need to Know Makes All the Difference in the World
- Diverse Populations Participating in Decisions About Your Care With Your Health Care TeamPart II of How Health Care Disparities May Influence Your Cancer Treatment and Care
- Understanding Diagnostic Technologies and Biomarkers
- Clinical Trials: How They Transform the Treatment of Cancer
- Understanding How Health Care Disparities May Influence Your Cancer Treatment and Care: With Tips and Strategies to Find the Best Cancer Treatment and Health Care Team for YouPart I of How Health Care Disparities May Influence Your Cancer Treatment and Care
- Understanding Diagnostic Technologies and Biomarkers
- Chemotherapy Treatment Side Effects: Prevention & Management
- Clinical Trials: How They Transform the Treatment of Cancer
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding How Health Care Disparities May Influence Your Cancer Treatment and Care: With Tips & Strategies to Find the Best Cancer Treatment & Health Care Team for YouPart I of How Health Care Disparities May Influence Your Cancer Treatment and Care
- Preventing, Managing & Treating Infection in Adults Living with Cancer
- How Health Care Disparities May Influence Your Cancer Treatment & Care
- Cancer and Flu Shots
- Treatment Adherence: Taking Your Pills on Schedule – Why It Is So Important
- What are Biosimilars? Understanding Their Role in Cancer Treatment: Current and Future Perspectives
- Participating in Decisions about Your CarePart IV of Life with Cancer: A Guide to Getting the Best Care
- Cancer and The Workplace: Understanding Your Legal ProtectionsPart III of Life with Cancer: A Guide to Getting the Best Care
- Understanding the Costs of Care and Your Health Care CoveragePart II of Life with Cancer: A Guide to Getting the Best Care
- Trends in Oncology and Treatment Planning: What You Need to KnowPart I of Life with Cancer: A Guide to Getting the Best Care
- Care for Your Bones During & After Cancer Treatment: Tips to Improve Bone Health
For Acute Lymphoblastic Leukemia
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- CAR T-Cell Therapy: What’s New
- Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
- New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)
- Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Transplantation as a Treatment Option for Blood Cancers
For Acute Myeloid Leukemia
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
- Acute Myelogenous Leukemia (AML): Current Treatment Perspectives
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- Acute Myeloid Leukemia (AML): Treatment Updates
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Transplantation as a Treatment Option for Blood Cancers
For Basal Cell Cancer
- New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell & Squamous Cell CancerPart I of Living with Advanced Skin Cancer and Melanoma
- Advanced Skin Cancer: New Perspectives in the Treatment of Advanced Basal Cell & Squamous Cell CancersPart I of Living with Advanced Skin Cancer and Melanoma
For Bladder Cancer
For Bone Cancer
For Brain Cancer
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart I of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- Glioblastoma in Adults: Treatment Updates
- Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting
For Breast Cancer
- Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 47th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer
- Updates from the 47th Annual San Antonio Breast Cancer Symposium (SABCS)Part I of Living with Breast Cancer
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Updates from the 47th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer
- Metastatic Triple Negative Breast Cancer: Strategies to CopePart I of Living with Metastatic Triple Negative Breast Cancer
- Triple Negative Breast Cancer and African American Women
- Updates from the American Society of Clinical Oncology (ASCO) 2024 on Triple Negative Breast Cancer
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart I of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- HER2-Positive Metastatic Breast Cancer: What’s New in Treatment and Quality of Life
- Breast Cancer in Younger Women: New Treatment Options
- Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Updates from the 46th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer
- Living with Breast Cancer - 46th Annual San Antonio Breast Cancer SymposiumPart I of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
- 2023 American Society of Clinical Oncology (ASCO) Annual Meeting: Triple Negative Breast Cancer Research Updates
- Metastatic Breast Cancer: Treatment Updates
- Early Stage Breast Cancer: New Treatment Approaches
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Lobular Breast Cancer: Treatment Progress
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Updates in the Treatment of Estrogen Receptor (ER), Progesterone Receptor (PR) and HER2 Positive Breast Cancer from the 45th Annual San Antonio Breast Cancer SymposiumPart II of Living with Breast Cancer – Updates from the 45th Annual San Antonio Breast Cancer Symposium (SABCS)
- Updates from the 45th Annual San Antonio Breast Cancer Symposium on Triple Negative Breast Cancer
- Living with Breast Cancer – Updates from the 45th San Antonio Breast Cancer Symposium (SABCS)Part I of Living with Breast Cancer – Updates from the 45th Annual San Antonio Breast Cancer Symposium (SABCS)
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
- Metastatic Breast Cancer: Treatment Updates
- Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting
- HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
- The Role of Radiation Therapy in the Treatment of Breast Cancer
- Metastatic Breast Cancer in African Americans: New Treatments
For Cervical Cancer
- Advances in the Treatment of Cervical Cancer
- Advances in the Treatment of Cervical Cancer
- Cervical Cancer: Treatment Advances
- Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting
- Cervical Cancer: Treatment Advances
For Chronic Lymphocytic Leukemia
- Update on Chronic Lymphocytic Leukemia (CLL)Part I of Living with Chronic Lymphocytic Leukemia
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Managing Chronic Lymphocytic Leukemia (CLL) and Its ComplicationsPart IV of Life with Chronic Lymphocytic Leukemia (CLL)
- Taking Your Blood Cancer Adherence Treatment on Schedule
- Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)Part II of Life with Chronic Lymphocytic Leukemia (CLL)
- Update on Chronic Lymphocytic Leukemia (CLL)Part I of Life with Chronic Lymphocytic Leukemia (CLL)
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Chronic Lymphocytic Leukemia (CLL): Treatment Updates
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- Chronic Lymphocytic Leukemia: What's NewPart I of Living with Chronic Lymphocytic Leukemia
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Transplantation as a Treatment Option for Blood Cancers
For Chronic Myelogenous Leukemia
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Transplantation as a Treatment Option for Blood Cancers
For Colorectal Cancer
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart II of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- Advances in the Treatment of Colorectal Cancer
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Advances in the Treatment of Colorectal Cancer
- Advances in the Treatment of Colorectal Cancer
- Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - "Advancing Equitable Cancer Care Through Innovation"Part II of Highlights from the 2022 ASCO Annual Meeting
- Colorectal Cancer Treatment: Progress and Advances
- Advances in the Treatment of Colorectal Cancer
For Cutaneous T-Cell Lymphoma
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Update On Marginal Zone Lymphoma (MZL)
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Transplantation as a Treatment Option for Blood Cancers
For Diffuse Large B-Cell Lymphoma
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches for Relapsed Refractory DLBCL
- Taking Your Blood Cancer Adherence Treatment on Schedule
- CAR T-Cell Therapy: What’s New
- Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Update On Marginal Zone Lymphoma (MZL)
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
For Endometrial Cancer
For Follicular Lymphoma
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- Update on Follicular Lymphoma
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
- Update on CAR T-Cell Therapies
- Follicular Lymphoma: Treatment Progress
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Update On Marginal Zone Lymphoma (MZL)
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- Follicular Lymphoma: Treatment Progress
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Transplantation as a Treatment Option for Blood Cancers
For Gastric Cancer
For Gastrointestinal Stromal Tumors
For Glioblastoma
For Head and Neck Cancer
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart I of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- Oral, Head and Neck Cancer: Treatment Updates
- Oral, Head & Neck Cancer: Treatment Update
- Treatment Update in Oral and Head and Neck Cancer
For Hodgkin Lymphoma
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Update On Marginal Zone Lymphoma (MZL)
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Transplantation as a Treatment Option for Blood Cancers
- Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
For Kidney Cancer
For Leukemia
- Update on Chronic Lymphocytic Leukemia (CLL)Part I of Living with Chronic Lymphocytic Leukemia
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart II of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- Managing Chronic Lymphocytic Leukemia (CLL) and Its ComplicationsPart IV of Life with Chronic Lymphocytic Leukemia (CLL)
- Taking Your Blood Cancer Adherence Treatment on Schedule
- Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)Part II of Life with Chronic Lymphocytic Leukemia (CLL)
- Update on Chronic Lymphocytic Leukemia (CLL)Part I of Life with Chronic Lymphocytic Leukemia (CLL)
- CAR T-Cell Therapy: What’s New
- Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
- New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
- Acute Myelogenous Leukemia (AML): Current Treatment Perspectives
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Chronic Lymphocytic Leukemia (CLL): Treatment Updates
- Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - "Advancing Equitable Cancer Care Through Innovation"Part II of Highlights from the 2022 ASCO Annual Meeting
- New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)
- Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
- Progress in the Treatment of Myelodysplastic Syndromes (MDS)
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- Acute Myeloid Leukemia (AML): Treatment Updates
- Chronic Lymphocytic Leukemia: What's NewPart I of Living with Chronic Lymphocytic Leukemia
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Transplantation as a Treatment Option for Blood Cancers
- Progress in the Treatment of Myelofibrosis
For Liver Cancer
For Lung Cancer
- Non-Small Cell Lung Cancer: Biomarker Testing and Treatment TrendsPart II of Living with Non-Small Cell Lung Cancer
- Non-Small Cell Lung Cancer: What’s NewPart I of Living with Non-Small Cell Lung Cancer
- Non-Small Cell Lung Cancer: Biomarker Testing and TreatmentPart II of Living with Non-Small Cell Lung Cancer
- Non-Small Cell Lung Cancer: What’s NewPart I of Living with Non-Small Cell Lung Cancer
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Diverse Populations Living with Non-Small Cell Lung Cancer
- Update on Small Cell Lung CancerPart I of Living with Small Cell Lung Cancer
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Non-Small Cell Lung Cancer: Biomarker Testing & Treatment TrendsPart II of Living with Non-Small Cell Lung Cancer
- Non-Small Cell Lung Cancer: What's NewPart I of Living with Non-Small Cell Lung Cancer
- Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - "Advancing Equitable Cancer Care Through Innovation"Part II of Highlights from the 2022 ASCO Annual Meeting
- Genomic Testing and Current Trends in the Treatment of Non-Small Cell Lung CancerPart III of Living with Non-Small Cell Lung Cancer
- Small Cell Lung Cancer: Treatment UpdatePart I of Living with Small Cell Lung Cancer
- Non-Small Cell Lung Cancer: Treatment AdvancesPart I of Living with Non-Small Cell Lung Cancer
- Advances in the Treatment of Lung CancerPart I of Living with Lung Cancer
- For Caregivers: Practical Tips for Coping with Your Loved One’s Lung CancerPart II of Living with Lung Cancer
For Lymphoma
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on Primary Central Nervous System Lymphoma (PCNSL)
- Update on CAR T-Cell Therapies
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart II of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart I of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches for Relapsed Refractory DLBCL
- Taking Your Blood Cancer Adherence Treatment on Schedule
- Update on Follicular Lymphoma
- CAR T-Cell Therapy: What’s New
- Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
- Update on CAR T-Cell Therapies
- Follicular Lymphoma: Treatment Progress
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - "Advancing Equitable Cancer Care Through Innovation"Part II of Highlights from the 2022 ASCO Annual Meeting
- Update On Marginal Zone Lymphoma (MZL)
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- Mantle Cell Lymphoma: Treatment UpdatePart I of Living with Mantle Cell Lymphoma (MCL)
- Follicular Lymphoma: Treatment Progress
- Marginal Zone Lymphoma (MZL): Treatment Updates
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Transplantation as a Treatment Option for Blood Cancers
- Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
- Treatment Update on Mantle Cell Lymphoma (MCL)Part I of Living with Mantle Cell Lymphoma
For Mantle Cell Lymphoma
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Update On Marginal Zone Lymphoma (MZL)
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- Mantle Cell Lymphoma: Treatment UpdatePart I of Living with Mantle Cell Lymphoma (MCL)
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
- Treatment Update on Mantle Cell Lymphoma (MCL)Part I of Living with Mantle Cell Lymphoma
For Marginal Zone Lymphoma
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Update On Marginal Zone Lymphoma (MZL)
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- Marginal Zone Lymphoma (MZL): Treatment Updates
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
For Melanoma
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart II of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma
- New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell & Squamous Cell CancerPart I of Living with Advanced Skin Cancer and Melanoma
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - "Advancing Equitable Cancer Care Through Innovation"Part II of Highlights from the 2022 ASCO Annual Meeting
- People of Color Living with Skin Cancer
- Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma
For Merkel Cell Carcinoma
For Mesothelioma
For Metastatic Breast Cancer
- Metastatic Triple Negative Breast Cancer: Strategies to CopePart I of Living with Metastatic Triple Negative Breast Cancer
- HER2-Positive Metastatic Breast Cancer: What’s New in Treatment and Quality of Life
- Breast Cancer in Younger Women: New Treatment Options
- Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Living with Breast Cancer - 46th Annual San Antonio Breast Cancer SymposiumPart I of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
- 2023 American Society of Clinical Oncology (ASCO) Annual Meeting: Triple Negative Breast Cancer Research Updates
- Metastatic Breast Cancer: Treatment Updates
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Lobular Breast Cancer: Treatment Progress
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Updates in the Treatment of Estrogen Receptor (ER), Progesterone Receptor (PR) and HER2 Positive Breast Cancer from the 45th Annual San Antonio Breast Cancer SymposiumPart II of Living with Breast Cancer – Updates from the 45th Annual San Antonio Breast Cancer Symposium (SABCS)
- Updates from the 45th Annual San Antonio Breast Cancer Symposium on Triple Negative Breast Cancer
- Living with Breast Cancer – Updates from the 45th San Antonio Breast Cancer Symposium (SABCS)Part I of Living with Breast Cancer – Updates from the 45th Annual San Antonio Breast Cancer Symposium (SABCS)
- Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
- Metastatic Breast Cancer: Treatment Updates
- HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
- The Role of Radiation Therapy in the Treatment of Breast Cancer
- Metastatic Breast Cancer in African Americans: New Treatments
For Multiple Myeloma
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- Diverse Populations Living with Multiple Myeloma: Treatment Advances
- Progress in the Treatment of Multiple MyelomaPart I of Living with Multiple Myeloma
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Progress in the Treatment of Multiple MyelomaPart I of Living with Multiple Myeloma
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Progress in the Treatment of Multiple Myeloma
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Transplantation as a Treatment Option for Blood Cancers
For Myelodysplastic Syndromes
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- Progress in the Treatment of Myelodysplastic Syndromes (MDS)
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Transplantation as a Treatment Option for Blood Cancers
For Myelofibrosis
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Transplantation as a Treatment Option for Blood Cancers
- Progress in the Treatment of Myelofibrosis
For Myeloproliferative Neoplasms
- Progress in the Treatment of Myeloproliferative Neoplasms (MPNs)Part I of Living with Myeloproliferative Neoplasms
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- Managing Treatment Side Effects, Aches and Pains from Myeloproliferative Neoplasms (MPNs)Part II of Living with Myeloproliferative Neoplasms (MPNs)
- Progress in the Treatment of Myeloproliferative Neoplasms (MPNs)Part I of Living with Myeloproliferative Neoplasms (MPNs)
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Transplantation as a Treatment Option for Blood Cancers
- Progress in the Treatment of Myelofibrosis
- Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
For Non-Hodgkin Lymphoma
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Update On Marginal Zone Lymphoma (MZL)
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Transplantation as a Treatment Option for Blood Cancers
- Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
For Ovarian Cancer
- Update on the Treatment of Ovarian Cancer
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart I of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- Update on the Treatment of Ovarian Cancer
- Ovarian Cancer: Treatment Updates
- Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting
- Medical Update on Ovarian Cancer
For Pancreatic Cancer
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart II of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- Pancreatic Cancer: Treatment Update
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting - "Advancing Equitable Cancer Care Through Innovation"Part II of Highlights from the 2022 ASCO Annual Meeting
For Peripheral T-Cell Lymphoma
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Update On Marginal Zone Lymphoma (MZL)
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
For Polycythemia Vera
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Transplantation as a Treatment Option for Blood Cancers
For Prostate Cancer
- Metastatic Prostate Cancer: Current Treatment AdvancesPart I of Living with Metastatic Prostate Cancer
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart I of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- Metastatic Prostate Cancer: Current Treatment AdvancesPart I of Living with Metastatic Prostate Cancer
- Metastatic Prostate Cancer: Current Treatment AdvancesPart I of Living with Metastatic Prostate Cancer
- Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting
- Advances in the Treatment of Metastatic Prostate Cancer
For Renal Cell Cancer
For Sarcoma
- Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to CurePart I of Highlights from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting: The Art and Science of Cancer Care from Comfort to Cure
- Highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting – “Advancing Equitable Cancer Care Through Innovation"Part I of Highlights from the 2022 ASCO Annual Meeting
- People of Color Living with Skin Cancer
For Skin Cancer
- Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma
- New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell & Squamous Cell CancerPart I of Living with Advanced Skin Cancer and Melanoma
- Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma
- Advanced Skin Cancer: New Perspectives in the Treatment of Advanced Basal Cell & Squamous Cell CancersPart I of Living with Advanced Skin Cancer and Melanoma
- People of Color Living with Skin Cancer
- Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma
For Small Lymphocytic Lymphoma
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Update On Marginal Zone Lymphoma (MZL)
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Transplantation as a Treatment Option for Blood Cancers
For Squamous Cell Cancer
- New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell & Squamous Cell CancerPart I of Living with Advanced Skin Cancer and Melanoma
- Advanced Skin Cancer: New Perspectives in the Treatment of Advanced Basal Cell & Squamous Cell CancersPart I of Living with Advanced Skin Cancer and Melanoma
- People of Color Living with Skin Cancer
- Emerging Treatments for Metastatic MelanomaPart II of Living with Advanced Skin Cancer and Melanoma
For Stomach Cancer
For Testicular Cancer
For Thyroid Cancer
For Triple Negative Breast Cancer
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Updates from the 47th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer
- Metastatic Triple Negative Breast Cancer: Strategies to CopePart I of Living with Metastatic Triple Negative Breast Cancer
- Triple Negative Breast Cancer and African American Women
- Updates from the American Society of Clinical Oncology (ASCO) 2024 on Triple Negative Breast Cancer
- Breast Cancer in Younger Women: New Treatment Options
- Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)Part II of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Updates from the 46th Annual San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer
- Living with Breast Cancer - 46th Annual San Antonio Breast Cancer SymposiumPart I of Living with Breast Cancer: Updates from the San Antonio Breast Cancer Symposium
- 2023 American Society of Clinical Oncology (ASCO) Annual Meeting: Triple Negative Breast Cancer Research Updates
- Metastatic Breast Cancer: Treatment Updates
- Early Stage Breast Cancer: New Treatment Approaches
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Lobular Breast Cancer: Treatment Progress
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Updates in the Treatment of Estrogen Receptor (ER), Progesterone Receptor (PR) and HER2 Positive Breast Cancer from the 45th Annual San Antonio Breast Cancer SymposiumPart II of Living with Breast Cancer – Updates from the 45th Annual San Antonio Breast Cancer Symposium (SABCS)
- Updates from the 45th Annual San Antonio Breast Cancer Symposium on Triple Negative Breast Cancer
- Living with Breast Cancer – Updates from the 45th San Antonio Breast Cancer Symposium (SABCS)Part I of Living with Breast Cancer – Updates from the 45th Annual San Antonio Breast Cancer Symposium (SABCS)
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
- Metastatic Breast Cancer: Treatment Updates
- HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
- The Role of Radiation Therapy in the Treatment of Breast Cancer
- Metastatic Breast Cancer in African Americans: New Treatments
For Uterine Cancer
For Vaginal Cancer
For Waldenstrom’s Macroglobulinemia
- Update from the 2024 American Society of Hematology (ASH) Annual Meeting
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Transplantation as a Treatment Option for Blood Cancers
- Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)